Literature DB >> 26142287

Preparing family physicians for the care of patients with severe and persistent mental illness: Examples from two U.S. residency programs.

Amy M Romain1, John Muench2, Julie P Phillips3.   

Abstract

Individuals with severe and persistent mental illness have increased morbidity and mortality and significant barriers to accessing health care. Although primary care providers deliver most health care for this population, residency training programs generally lack specialized training in this area. This article describes the approaches of two family medicine residency programs in addressing this educational gap. Each program collaborated with external organizations to create service models that would enhance patient access, while immersing residents in the care of patients with severe and persistent mental illness. Residents educated in these programs gain experience with an underserved population, practice advanced skills in managing complex medical and psychiatric illness, and increase knowledge from collaborative work in unique care settings. Further implementation of programs like these, and rigorous study of such programs, could have significant benefits for family medicine education and the care of patients with severe and persistent mental illness.
© The Author(s) 2015.

Entities:  

Keywords:  SPMI; collaborative care; family medicine; graduate medical education; primary care; serious and persistent mental illness; severe and persistent mental illness; underserved populations

Mesh:

Year:  2015        PMID: 26142287     DOI: 10.1177/0091217415592353

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  1 in total

1.  Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study.

Authors:  Lori E Ross; Simone Vigod; Jessica Wishart; Myera Waese; Jason Dean Spence; Jason Oliver; Jennifer Chambers; Scott Anderson; Roslyn Shields
Journal:  BMC Fam Pract       Date:  2015-10-13       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.